Discussing sickle cell disease (SCD) therapy choices with patients and caregivers is an ongoing dialogue throughout the course of treatment. Clinical trials may be an important consideration, especially for patients with an aggressive disease course. A consultation for hematopoietic cell transplantation (HCT), the only potentially curative therapy, may be indicated.
On this page, you will find educational activities on the latest treatment guidelines and choices, clinical trials and resources. These are available to you, your patients and caregivers to care for and support treatment decisions with pediatric and adult patients with SCD.